New Hope for Tough-to-Treat Stomach Cancer

Amgen’s latest cancer drug just hit a major milestone! Their experimental therapy, bemarituzumab, helped advanced gastric cancer patients live longer when paired with chemo in a big late-stage trial. The catch? Some folks had eye issues and nausea, so doctors are keeping a close watch on side effects. Still, this could be a game-changer for people with few options. More details are coming soon—fingers crossed for more good news! #CancerResearch #MedicalBreakthrough #Amgen #Health #BodyHealth